BNGOW - Bionano Genomics, Inc.
0 0%
Share volume: 0
Last Updated:
Measuring And Control Equipment/Lab Analytical Instruments:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2025 | 08-14-2025 | 11-13-2025 | 03-23-2026 | |
| Assets | |||||
| Total Assets | 78.414 M | 76.010 M | 79.062 M | 73.584 M | |
| Current Assets | 44.929 M | 42.662 M | 48.800 M | 45.386 M | |
| Inventories | 9.562 M | 8.633 M | 7.049 M | 5.448 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 14.606 M | 12.876 M | 18.516 M | 16.279 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.625 M | 3.562 M | 3.065 M | 2.990 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 18.339 M | 17.264 M | 16.172 M | 14.847 M | |
| Other Assets | 15.146 M | 16.084 M | 14.090 M | 13.351 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 78.414 M | 76.010 M | 79.062 M | 73.584 M | |
| Total liabilities | 30.226 M | 30.636 M | 29.263 M | 29.160 M | |
| Total current liabilities | 26.408 M | 24.178 M | 22.977 M | 22.942 M | |
| Accounts Payable | 6.562 M | 6.244 M | 5.990 M | 5.590 M | |
| Other liabilities | 3.526 M | 6.215 M | 6.094 M | 5.969 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 3.526 M | 6.215 M | 6.094 M | 5.969 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 48.188 M | 45.374 M | 49.799 M | 44.424 M | |
| Common stock | 744.501 M | 748.568 M | 761.480 M | 764.027 M | |
| Retained earnings | -696.327 M | -703.184 M | -711.687 M | -719.620 M |